YAP inhibitors could facilitate targeted treatment of basal-like breast cancer

[News]

Targeted treatment of basal-like breast cancer could be facilitated by YAP inhibitors in the future. As reported by an MDC team headed by Walter Birchmeier in the scientific journal Cancer Research, this type of cancer requires the support of the YAP protein to stimulate the growth of cancer stem cells.

More... (https://www.news-medical.net/news/20210322/YAP-inhibitors-could-facilitate-targeted-treatment-of-basal-like-breast-cancer.aspx)